A Study To Assess the Likelihood ratio of Natrum Muriaticum in rubric head-pain-sun, from exposure to.

Likelihood ratio of Natrum Muriaticum for the rubric head-pain-sun, from exposure to from Kent repertory an experimental study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/077608

Enrollment

354

Registered

2024-12-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G448- Other specified headache syndromes

Interventions

Intervention1: Natrum Muriaticum: Oral administration Of Natrum Muriaticum in lower potency 6C Or 30C will be given in form of globules size 30, doses and repetion-BD Or TDS and will be followed after

Eligibility

Inclusion criteria

Inclusion criteria: 1.Head-pain-sun, from exposure to VAS scale more than 3 2.Patients suffering from headache from sun exposure. 3.Cases giving consent.

Exclusion criteria

Exclusion criteria: 1.Immuno-compromised patients 2.Pregnant women and lactating mothers 3.Known case with multi systemic illness 4.Patient not willing to give informed consent

Design outcomes

Primary

Measure	Time frame
Pain relief in "head-pain-sun, exposure to"(rubric) using VAS ScalesTimepoint: Pre score will be taken at baseline of treatment and post score will be assessed at the end of 24 weeks using VAS Scale.	—

Secondary

Measure	Time frame
MONARCH CRITERIA FOR FOLLOW UPTimepoint: EVERY 15 DAYS	—

Countries

India

Contacts

Public ContactDr. Anvesha Yadav

Dr. MPK Homeopathic Medical College Hospital And Research Centre

bidwalkars@gmail.com9414078227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026